INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 18, 2009 |
SVP Clinical Development
|
SVP Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,543 | -- | 14,543 |
| Dec 17, 2008 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 |
| Dec 17, 2008 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Dec 17, 2007 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,562 | -- | 4,562 |
| Dec 17, 2007 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,438 | -- | 25,438 |
| Dec 18, 2006 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 20,000 |
| Oct 02, 2006 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,572 | -- | 25,572 |
| Oct 02, 2006 |
SVP, Clinical Development
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 74,428 | -- | 74,428 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.